IOL Chemicals & Pharmaceuticals is currently trading at Rs. 66.30, up by 6.00 points or 9.95% from its previous closing of Rs. 60.30 on the BSE.
The scrip opened at Rs. 62.95 and has touched a high and low of Rs. 66.30 and Rs. 62.95 respectively. So far 155626 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 155.95 on 23-Sep-2016 and a 52 week low of Rs. 58.95 on 12-Apr-2017.
Last one week high and low of the scrip stood at Rs. 66.95 and Rs. 58.95 respectively. The current market cap of the company is Rs. 372.64 crore.
The promoters holding in the company stood at 39.92%, while Institutions and Non-Institutions held 0.13% and 59.95% respectively.
IOL Chemicals & Pharmaceuticals has received EUGMP Certification from National Institute of Pharmacy and Nutrition, Hungary, for its product Ibuprofen, Lamotrigine, Metformin Hydrochloride confirming compliance with principals of Good Manufacturing Practices as provided by European Union Legislation. This will facilitate the company to expand its product portfolio in the European Market.
IOL Chemicals & Pharmaceuticals is one of the largest manufacturers of APIs and specialty chemicals with presence in over 57 countries across the world. It manufactures and supplies APIs and specialty chemicals for use in various pharmaceutical, textile, packaging, lamination, pesticides and food processing applications.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: